細胞治療監測試劑盒市場規模、佔有率和成長分析：按產品類型、細胞類型、應用、最終用戶、技術和地區分類－2026-2033年產業預測

2024 年全球細胞治療監測試劑盒市場價值為 19.6 億美元，預計到 2025 年將成長至 21.2 億美元，到 2033 年將成長至 40.6 億美元，在預測期（2026-2033 年）內複合年成長率為 8.4%。

全球細胞治療監測試劑盒市場日益重要，其主要驅動力在於對診斷工具的需求，以確保細胞產品在生產和臨床應用中的活性、療效和安全性。這一成長主要得益於細胞治療產品線的不斷擴展，使得可靠的監測解決方案對於預防批次缺陷和及時獲得監管部門批准至關重要。對符合良好生產規範 (GMP) 的設施投資增加以及大型生物技術公司的進入，已將該市場從分散的細分市場轉變為更一體化的行業。此外，CAR-T 等新型門診療法的出現以及快速出貨前檢測能力的提升，正在創造新的機會和收入來源，並促使業內企業建立戰略聯盟，以提高生產效率和市場覆蓋範圍。

全球細胞治療監測試劑盒市場促進因素

全球對細胞治療監測試劑盒的需求主要源自於醫療保健產業在生產過程和臨床應用過程中準確評估細胞活力、效力和表現型的迫切需求。即時監測對於維持治療效果和保障病人安全至關重要。及時發現異常情況有助於採取糾正措施，從而保護產品質量，最大限度地減少批次缺陷，並加快產品上市速度。因此，製造商正致力於採用能夠提供快速可靠數據的先進監測試劑盒，這推動了全球各類研究機構、商業生產基地和專業治療中心的需求，並支持多樣化的治療途徑和創新的細胞療法策略。

全球細胞治療監測試劑盒市場的限制因素

全球細胞治療監測試劑盒市場面臨許多挑戰，主要原因是複雜試劑、專用抗體和高精度設備相關的高昂製造成本。這些飆升的成本限制了小規模生物技術公司和學術機構的採購能力，使其難以建立全面的監測系統。因此，預算有限的機構可能會延遲採用這些試劑盒，轉而依賴精確度較低的替代方案，或將監測活動限制在必要的查核點。儘管臨床益處已得到認可，但這最終阻礙了市場成長。此外，專業培訓和持續的監管合規要求也增加了經濟負擔，進一步限制了其普及。

細胞治療監測試劑盒市場的全球趨勢

全球細胞治療監測試劑盒市場正經歷著向數位化平台的顯著轉變，這些平台整合了數據採集、檢測自動化和即時分析功能。作為這一發展趨勢的一部分，供應商正在將基於雲端的儀錶板和人工智慧驅動的決策支援工具整合到試劑盒中，使臨床醫生能夠在整個生產過程中監測療效、存活率和安全性參數。這種一致的整合減少了人工解讀，加快了批次放行流程，並增強了可追溯性，最終提升了相關人員的信心。因此，創新細胞療法的全球部署正在加速，同時透過不斷更新的標準化報告方案確保了合規性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球細胞治療監測試劑盒市場規模：依產品類型分類

• 細胞活力檢測試劑盒
• 細胞計數試劑盒
• 細胞表現型分析試劑盒
• 細胞功能檢測試劑盒

全球細胞治療監測試劑盒市場規模：依細胞類型分類

• T細胞
• 幹細胞
• NK細胞
• 樹突狀細胞

全球細胞治療監測試劑盒市場規模：依應用領域分類

• 細胞療法的發展
• 細胞療法的生產
• 品管

全球細胞治療監測套件市場規模：依最終用戶分類

• 生技公司
• 製藥公司
• 學術研究機構
• 受託研究機構

全球細胞治療監測試劑盒市場規模：依技術分類

• 流式細胞技術
• 影像
• 分子檢測

全球細胞治療監測試劑盒市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Merck KGaA
• Lonza Group AG
• Revvity, Inc.
• Agilent Technologies, Inc.
• BD（Becton, Dickinson and Company）
• Miltenyi Biotec BV & Co. KG
• STEMCELL Technologies Inc.
• Bio-Techne Corporation
• Charles River Laboratories International, Inc.
• FUJIFILM Irvine Scientific
• Cytiva
• Promega Corporation
• QIAGEN NV
• Takara Bio Inc.
• Cytek Biosciences, Inc.
• Cell Signaling Technology, Inc.

結論與建議

Global Cell Therapy Monitoring Kits Market size was valued at USD 1.96 Billion in 2024 and is poised to grow from USD 2.12 Billion in 2025 to USD 4.06 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global market for cell therapy monitoring kits is increasingly vital, driven by the need for diagnostic tools that ensure the viability, potency, and safety of cellular products during manufacturing and clinical application. This growth is largely fueled by the expansion of cell therapy pipelines, where the demand for reliable monitoring solutions becomes crucial to prevent batch failures and ensure timely regulatory approvals. The market has evolved from a fragmented niche to a more consolidated sector due to increased investments in good manufacturing practices (GMP) facilities and the involvement of major biotech companies. Additionally, emerging outpatient therapies, like CAR-T, alongside rapid release testing capabilities, are shaping new opportunities and revenue streams, prompting strategic partnerships within the industry to enhance production efficiency and market reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Therapy Monitoring Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Therapy Monitoring Kits Market Segments Analysis

Global cell therapy monitoring kits market is segmented by product type, cell type, application, end user, technology and region. Based on product type, the market is segmented into Cell Viability Kits, Cell Counting Kits, Cell Phenotyping Kits and Cell Function Assay Kits. Based on cell type, the market is segmented into T Cells, Stem Cells, NK Cells and Dendritic Cells. Based on application, the market is segmented into Cell Therapy Development, Cell Therapy Manufacturing and Quality Control. Based on end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic & Research Institutes and Contract Research Organizations. Based on technology, the market is segmented into Flow Cytometry, Imaging and Molecular Assays. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Therapy Monitoring Kits Market

The demand for Global Cell Therapy Monitoring Kits is significantly driven by the healthcare industry's need for accurate assessments of cellular viability, potency, and phenotype throughout both manufacturing processes and clinical applications. Real-time monitoring is critical for maintaining therapeutic efficacy and ensuring patient safety. Instant detection of any deviations allows for timely corrective measures, safeguarding product quality, minimizing batch failures, and expediting the time to market. Consequently, manufacturers emphasize the adoption of advanced monitoring kits that provide rapid and reliable data, which propels demand across various research organizations, commercial production sites, and specialized therapeutic centers globally, catering to diverse treatment pathways and innovative cell-based strategies.

Restraints in the Global Cell Therapy Monitoring Kits Market

The Global Cell Therapy Monitoring Kits market faces significant challenges primarily due to the high production costs associated with complex reagents, specialized antibodies, and precise instrumentation. These elevated costs hinder the purchasing capabilities of smaller biotech companies and academic institutions, restricting their ability to establish comprehensive monitoring initiatives. As a result, budget-conscious organizations may delay the adoption of these kits, resort to less accurate alternative methods, or restrict their monitoring efforts to essential checkpoints, which ultimately impedes market growth despite acknowledged clinical advantages. Furthermore, the necessity for specialized training and adherence to ongoing regulatory compliance contributes to the financial strain, further limiting widespread acceptance.

Market Trends of the Global Cell Therapy Monitoring Kits Market

The Global Cell Therapy Monitoring Kits market is experiencing a notable trend towards integrated digital platforms that amalgamate data capture, assay automation, and real-time analytics. This evolution features vendors incorporating cloud-based dashboards and AI-driven decision support tools into their kits, which empowers clinicians to monitor potency, viability, and safety parameters throughout the manufacturing process. Such cohesive integration diminishes manual interpretation, expedites batch release, and bolsters traceability, ultimately fostering increased trust among stakeholders. As a result, the adoption of innovative cell-based therapies accelerates globally, all while adhering to regulatory compliance through continually updated standardized reporting protocols.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cell Therapy Monitoring Kits Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Cell Viability Kits
• Cell Counting Kits
• Cell Phenotyping Kits
• Cell Function Assay Kits

Global Cell Therapy Monitoring Kits Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• T Cells
• Stem Cells
• NK Cells
• Dendritic Cells

Global Cell Therapy Monitoring Kits Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cell Therapy Development
• Cell Therapy Manufacturing
• Quality Control

Global Cell Therapy Monitoring Kits Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biotechnology Companies
• Pharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations

Global Cell Therapy Monitoring Kits Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Flow Cytometry
• Imaging
• Molecular Assays

Global Cell Therapy Monitoring Kits Market Size & CAGR (2026-2033)

• North America (Product Type, Cell Type, Application, End User, Technology)
  • US
  • Canada
• Europe (Product Type, Cell Type, Application, End User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Cell Type, Application, End User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Cell Type, Application, End User, Technology)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Cell Type, Application, End User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec B.V. & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytek Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations